CTRI/2026/07/113358进行中(未招募)不适用
Evaluating the effectiveness of WHOs Integrated Care for Older People (ICOPE) approach-based training module among caregivers of elderly people with neurological and psychiatric disorders. - NIL
National Institute of Mental Health and Neurosciences Bengaluru Karnataka0 个研究点目标入组 40 人开始时间: 2026年7月16日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age more than 18 years old.
- •Caregivers who are providing care to the elderly with neurological and psychiatric disorders at selected old age homes and have at least a month of experience.
- •Caregiver with a similar role and responsibilities in caregiving to elderly people with neurological and psychiatric disorders.
- •Paid caregivers other than health care professionals.
- •Caregivers who are fluent in Hindi or English.
排除标准
- •Caregivers who have previously undergone ICOPE-related training.
研究者
相似试验
招募中
1 期
A Phase I study to evaluate the safety and efficacy of L19IL2 in combination with ruxolitinib in patients with advanced solid tumors.2025-522243-17-00Philogen S.p.A.96
招募中
2 期
Evaluation of the safety and efficacy of Continuous Dopaminergic Stimulation by intracerebroventricular administration of anaerobically conserved dopamine in Parkinson's disease at the motor fluctuation stage: Single-center pilot studyParkinson's disease2024-517566-42-00Centre Hospitalier Universitaire De Lille, InBrain Pharma12
招募中
不适用
JBCRG-M11 ( CAERUS trial )
(JBCRG-M11 ( CAERUS trial ))Hormone receptor-positive and HER2-low metastatic breast cancerjRCT2051260024110
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
2 期
A Phase 1/2, Umbrella Study of the Efficacy and Safety of Pembrolizumab plus Enfortumab vedotin +/- Investigational Agents in First-Line metastatic urothelial carcinoma2023-506385-30-00Merck Sharp & Dohme LLC37
